Home > Insider Trading > Filing (0001209191-17-008661)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1488613	Foundation Medicine Inc.	FMI	Services-Medical Laboratories (8071)	271316416

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1585005	J. Steven Kafka	150 Second Street C/O Foundation Medicine, Inc. Cambridge MA 02141	President & Coo	No	Yes	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2017-02-06	52,855	$18.92	146,015	No	4	A	Direct
Common Stock	Disposition	2017-02-08	10,415	$23.24	135,600	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	A	Direct
No	4	S	Direct

Footnotes

Represents restricted stock units granted by the Issuer pursuant to its 2013 Stock Option and Incentive Plan. These restricted stock units will vest in their entirety on 2/6/2018.
The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 19, 2016.
The price reported in this Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $23.00 to $23.625, inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the ranges set forth in this footnote.